35 research outputs found
GITR expression on T-cell receptor-stimulated human CD8+ T cell in a JNK-dependent pathway
Glucocorticoid-induced tumor necrosis factor receptor (TNFR) (GITR)
family-related gene is a member of the TNFR super family. GITR works as
one of the immunoregulatory molecule on CD4+ regulatory T cells and has
an important role on cell survival or cell death in CD4+ T cells.
Little is known about the expression of GITR on human CD8+ T cells on
antigen-specific and non-specific activation. Here, we report that
expression of GITR on human CD8+ T cells on T-cell receptor (TCR)
(anti-CD3)-mediated stimulation is dependent on the JNK pathway. The
activation of CD8+ T cells was measured by the expression of IL-2
receptor-\u3b1 (CD25), GITR and by IFN-\u3b3 production upon
re-stimulation with anti-CD3 antibody. We studied the signaling pathway
of such inducible expression of GITR on CD8+ T cells. We found that a
known JNK-specific inhibitor, SP600125, significantly down-regulates
GITR expression on anti-CD3 antibody-mediated activated CD8+ T cells by
limiting JNK phosphorylation. Subsequently, after stimulation of the
CD8+ cells, we tested for the production of IFN-\u3b3 by the activated
cells following restimulation with the same stimulus. It appears that
the expression of GITR on activated human CD8+ T cells might also be
regulated through the JNK pathway when the activation is through TCR
stimulation. Therefore, GITR serves as an activation marker on
activated CD8+ cells and interference with JNK phosphorylation,
partially or completely, by varying the doses of SP600125 might have
implications in CD8+ cytotoxic T cell response in translational
research
Aligning Santal Tribe Menu Templates with EAT-Lancet Commissionâs Dietary Guidelines for Sustainable and Healthy Diets: A Comparative Analysis
Background: In the context of global shifts in food systems, this paper explores the unique dietary practices of the Santal tribe, an indigenous group in eastern India, to understand the health, nutrition, and sustainability aspects of their traditional food systems. This study evaluates the nutritional content of the Santal diet in comparison to the EAT-Lancet Commissionâs 2019 dietary guidelines for healthy and sustainable diets. Methods: The University of East Anglia, in collaboration with the NNEdPro Global Institute for Food, Nutrition and Health in Cambridge, PRADAN; colleagues in India and local Santal youth, conducted nutritional analyses of traditional Santal recipes. Two menu templates, Kanhu Thali and Jhano Thali, were selected for comparative analysis based on their representation of diverse dietary practices within the Santal community. Nutritional data, including energy as well as the distribution of macronutrients and micronutrients, were compiled and compared with the EAT-Lancet guidelines. Results: The Santal menu templates (nutritionally complete meals) demonstrated alignment with EAT-Lancet recommendations in aspects such as whole grains, starchy vegetables, vegetables, plant-based protein sources, unsaturated fats, and limited added sugars. However, notable deviations included the absence of animal-based protein sources and dairy. The Santal diet showed high protein intake, largely from plant-based sources, and emphasised the importance of whole grains. Seasonal variations in nutritional content were observed between the two templates. Conclusions: While the Santal diet aligns with some aspects of global dietary guidelines, there are notable deviations that underscore the complexity of aligning traditional diets with universal recommendations. The findings emphasise the need for culturally sensitive dietary recommendations that respect traditional diets while promoting sustainability. Research needs to support tailored global guidelines enshrining core principles of nutritional adequacy which are inter-culturally operable in order to accommodate cultural diversity, local practices, and seasonal variations, crucial for fostering sustainable and healthy eating habits in diverse sociodemographic contexts
CD4âșCD25â» T Cells Transduced to Express MHC Class I-Restricted Epitope-Specific TCR Synthesize Th1 Cytokines and Exhibit MHC Class I-Restricted Cytolytic Effector Function in a Human Melanoma Model
Cytolytic T cell-centric active specific and adoptive immunotherapeutic approaches might benefit from the simultaneous engagement of CD4âș T cells. Considering the difficulties in simultaneously engagingCD4âș and CD8âș T cells in tumor immunotherapy, especially in an Ag-specific manner, redirecting CD4âș T cells to MHC class I-restricted epitopes through engineered expression of MHC class I-restricted epitope-specific TCRs in CD4âș T cells has emerged as a strategic consideration. Such TCR-engineered CD4âș T cells have been shown to be capable of synthesizing cytokines as well as lysing target cells. We have conducted a critical examination of functional characteristics of CD4âș T cells engineered to express the α- and ÎČ-chains of a high functional avidity TCR specific for the melanoma epitope, MART-1, as a prototypic human tumor Ag system. We found that unpolarized CD4âșCD25â» T cells engineered to express the MART-1 TCR selectively synthesize Th1 cytokines and exhibit a potent Ag-specific lytic granule exocytosis-mediated cytolytic effector function of comparable efficacy to that of CD8âș CTL. Such TCR engineered CD4âș T cells, therefore, might be useful in clinical immunotherapy
Immunoregulation through IL-10 gene expression and the fate of cytotoxic T lymphocyte-mediated tumor immunotherapy
Gene analysis of tumor associated antigens revealed that tumor antigens are all normal gene product. Inducing tumor reactive cytotoxic T lymphocytes (CT) in the patients is same as inducing autoimmunity in the patients. Immunosuppressive cytokine interleukin-10 (IL-10) plays an important role in maintaining homeostasis or tolerance. To break the tumor tolerance, blocking and IL-10 secretion or intervention in the pathways of IL-10 gene activation is indeed important
T Cells Expanded in Presence of IL-15 Exhibit Increased Antioxidant Capacity And Innate Effector Molecules
Persistence of effector cytotoxic T lymphocytes (CTLs) during an immunological response is critical for successfully controlling a viral infection or tumor growth. Various cytokines are known to play an important part in regulating the immune response. The IL-2 family of cytokines that includes IL-2 and IL-15 are known to function as growth and survival factors for antigen-experienced T cells. IL-2 and IL-15 possess similar properties, including the ability to induce T cell proliferation. Whereas long term IL-2 exposure has been shown to promote apoptosis and limit CD8+ memory T cell survival and proliferation, it is widely believed that IL-15 can inhibit apoptosis and helps maintain a memory CD8+ T-cell population. However, mechanisms for superior outcomes for IL-15 as compared to IL-2 are still under investigation. Our data shows that human T cells cultured in the presence of IL-15 exhibit increased expression of anti-oxidant molecules Glutathione reductase (GSR), Thioredoxin reductase 1 (TXNDR1), Peroxiredoxin (PRDX), Superoxide dismutase (SOD). An increased expression of cell-surface thiols, intracellular glutathione, and thioredoxins was also noted in IL-15 cultured T cells. Additionally, IL-15 cultured T cells also showed an increase in cytolytic effector molecules. Apart from increased level of Granzyme A and Granzyme B, IL-15 cultured T cells exhibit increased accumulation of reactive oxygen (ROS) and reactive nitrogen (RNS) species as compared to IL-2 cultured T cells. Overall, this study suggests that T cells cultured in IL-15 show increase persistence not only due to increased anti-apoptotic proteins but also due to increased anti-oxidant levels, which is further complimented by increased cytolytic effector functions
GITR expression on T-cell receptor-stimulated human CD8+ T cell in a JNK-dependent pathway
Glucocorticoid-induced tumor necrosis factor receptor (TNFR) (GITR)
family-related gene is a member of the TNFR super family. GITR works as
one of the immunoregulatory molecule on CD4+ regulatory T cells and has
an important role on cell survival or cell death in CD4+ T cells.
Little is known about the expression of GITR on human CD8+ T cells on
antigen-specific and non-specific activation. Here, we report that
expression of GITR on human CD8+ T cells on T-cell receptor (TCR)
(anti-CD3)-mediated stimulation is dependent on the JNK pathway. The
activation of CD8+ T cells was measured by the expression of IL-2
receptor-α (CD25), GITR and by IFN-γ production upon
re-stimulation with anti-CD3 antibody. We studied the signaling pathway
of such inducible expression of GITR on CD8+ T cells. We found that a
known JNK-specific inhibitor, SP600125, significantly down-regulates
GITR expression on anti-CD3 antibody-mediated activated CD8+ T cells by
limiting JNK phosphorylation. Subsequently, after stimulation of the
CD8+ cells, we tested for the production of IFN-Îł by the activated
cells following restimulation with the same stimulus. It appears that
the expression of GITR on activated human CD8+ T cells might also be
regulated through the JNK pathway when the activation is through TCR
stimulation. Therefore, GITR serves as an activation marker on
activated CD8+ cells and interference with JNK phosphorylation,
partially or completely, by varying the doses of SP600125 might have
implications in CD8+ cytotoxic T cell response in translational
research